Congratulations to Dr. Sueh-li Lim on Side-by-Side Posters at ASH25 - Georgia McCaughan (Georgia McCaughan) Australasian Myeloma Research Consortium (AMaRC) oncodaily.com/voices/424952 #OncoDaily #Oncology #Cancer #Health #Medicine

Both Gosford & Wyong Hospitals are now recruiting for Dara@Home! Dara@Home is evaluating the feasibility & effectiveness of a program allowing #RRMM patients to self-administer daratumumab at home after receiving appropriate training. More info: amarconline.org/clinical-trial…

REGISTER: thelimbic.com/haematology/as… We're kicking off our haematology events for 2026 with the ASH 2025 highlights series. Join our experts in Brisbane, Melbourne & Sydney as they cover the best from the conference & discuss impacts on AUS practice. Miles Prince Georgia McCaughan

The inMMyCAR FIH trial of KLN-1010 (in-vivo CAR-T), which includes 4 AMaRC investigators (Prof. Simon Harrison, Prof. Joy Ho, Dr. Sueh-li Lim, Prof. Andrew Spencer) is mentioned in IMF's Top 10 Myeloma Research Breakthroughs at ASH 2025! Abstract link: ashpublications.org/blood/article/…

BelaCarD cohort 2 (CPI: Hang Quach), aka BelaCarD Extend using Belamaf-Kd (lower dose belamaf, every 3rd month), has begun recruitment with first site at The Alfred. More sites to follow. Click here to read more: amarconline.org/news/belacard-… #myeloma #belantamab

REGISTER: thelimbic.com/haematology/as… Join us in-person or watch online as experts present their selection of transformational clinical data from ASH 2025 and discuss the impacts for practice. Hang Quach Miles Prince

Learn what multiple myeloma is as March #MyelomaActionMonth nears. Share the first of this 8-part series to help raise awareness and educate others about myeloma. #MoreThanMyeloma #AskTheIMF Joseph Mikhael

BelaCarD Cohort 2 is recruiting at Royal Adelaide Hospital ! This 2nd cohort will again look at safety & efficacy of belantamab mafodotin, carfilzomib, & dexamethasone, with the dose level & frequency of belamaf further reduced from that of cohort 1. More info: amarconline.org/clinical-trial…

This March, during Myeloma Action Month, learn how myeloma is treated, and help us raise awareness with #MoreThanMyeloma. #MyelomaActionMonth #AskTheIMF Joseph Mikhael

Awareness saves time, and time saves lives. Join us in supporting Myeloma Action Month and help spread the word. #MoreThanMyeloma #MyelomaActionMonth

This year, #MyelomaAustralia's national myeloma seminar is taking a new approach. Instead of a live event, they're presenting the seminar in a movie-style format, available to watch anytime and anywhere throughout March. Have a look! youtu.be/VL03RulsGBU?si…

#MoreThanMyeloma #MyelomaActionMonth #mmsm #cancerresearch

BelaCarD Cohort 2 is now opened at Concord Hospital Health System in NSW! More information about BelaCarD is available at: amarconline.org/clinical-trial…

We're at the H3 Symposium this weekend. Some of our AMaRC investigators including Dr. Sueh-li Lim, Dr. Nick Weber, Prof. Hang Quach and Prof. Andrew Spencer are guest speakers and will be covering a variety of myeloma topics. Come visit at the AMaRC trade stall!

There's still time to watch Myeloma Australia's National Myeloma Month Movie during National Myeloma Month! youtube.com/watch?v=VL03Ru…

#MoreThanMyeloma #MyelomaActionMonth

#MoreThanMyeloma #MyelomaActionMonth #mmsm

Our ZEPFHR-MM study (Domain 1 - Tec/Tal) has fully recruited! We would like to thank all our sites for their support. We hope to present some preliminary results later in the year. Stay tuned.

The broader economic impact of myeloma in Australia beyond the patient/carer experience was recently reported by Myeloma Australia. You can find out more here: myeloma.org.au/economic-burde…

We are excited to announce our 1st patient has been recruited to BelaCarD Extend at St Vincent's Hospital Sydney! While still a combination of belamaf+Kd, BelaCarD Extend utilises a regimen that is even less intense than cohort 1. More info: amarconline.org/clinical-trial… #mmsm #rrmm